GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Bendrieji vaistų gamintojai

Mr. David Simon Redfern BSc (Hons), CA

President of Corporate Development

Mr. Philip C. Thomson

President of Global Affairs

Mr. James  Ford

Senior Vice President & Group General Counsel of Legal & Compliance

Mr. Luke V. Miels

Chief Commercial Officer

Ms. Emma Natasha Walmsley

Chief Executive Officer & Director

Ms. Julie Belita Brown

Chief Financial Officer & Executive Director

Mr. Tony  Wood

Chief Scientific Officer

Ms. Sarah  Elton-Farr

Head of Investor Relations

Ms. Sally  Jackson

Senior Vice President of Global Communications & Chief Executive Officer Office

Ms. Diana  Conrad

Chief People Officer

Pavadinimas	Rinkos kapitalizacija
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.	0M
Otsuka Holdings Co., Ltd.	0M
Merck & Co., Inc.	0M
Amgen Inc.	0M
Hunan Jingfeng Pharmaceutical Co.,Ltd.	0M
JCR Pharmaceuticals Co., Ltd.	0M
Bristol-Myers Squibb Company	0M
Luye Pharma Group Ltd.	0M
Mayne Pharma Group Limited	0M
Horizon Therapeutics Public Limited Company	0M

GSK plc

GSK plc Konkurentų sąrašas

Pagrindiniai konkurentai